Abstract
Background
Racial disparities exist for patients with pancreatic cancer. This observation has primarily been noted in the Surveillance, Epidemiology, and End Results database and has focused primarily on whites and African Americans. We sought to determine if these disparities exist in a local, racially diverse patient population.
Methods
Retrospective review of a pancreatic cancer tumor registry from two hospital systems from 1998 to 2010. Clinicopathologic parameters were recorded. Statistical analysis was performed by analysis of variance, Chi square test, Kaplan–Meier survival analysis, log rank test, and regression models.
Results
A total of 1039 patients were identified for this study. Hispanic and African American patients presented at an earlier age when compared to whites. There was no difference in gender or stage at presentation between racial groups. Adjusted for stage, race was predictive of chemotherapy administration. Independent predictors of increased mortality included male gender, African American race, stage at diagnosis, and older age.
Conclusions
Despite adjusting for covariates, survival remains lowest for African American patients. Further investigation is needed to understand the effect of race and how it mediates treatment and survival in those with pancreatic cancer.
Similar content being viewed by others
References
Agency for Healthcare Research and Quality. 2010 national healthcare quality and disparities reports. http://www.ahrq.gov/qual/qrdr10.htm.
Murray CJ, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and race–counties in the United States. PLoS Med. 2006;3:e260.
American Cancer Society. Cancer facts and figures, 2010. http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf.
Gehlert S, Colditz GA. Cancer disparities: unmet challenges in the elimination of disparities. Cancer Epidemiol Biomarkers Prev. 2011;20:1809–14.
Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009;115:3979–90.
Riall TS, Townsend CM Jr, Kuo YF, et al. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116:930–9.
Cheung MC, Yang R, Byrne MM, et al. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer. 2010;116:723–33.
U.S. Census Bureau. State and county quickfacts, 2010. http://quickfacts.census.gov/qfd/index.html.
Steyerberg EW, Eijkemans MJ, Harrell FE Jr, et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059–79.
Harrell WA, Spaulding LM. Social psychological models of choice behavior and drivers’ left turns. J Soc Psychol. 2001;141:714–22.
Royston P, Moons KG, Altman DG, et al. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.
Cummings P. Estimating adjusted risk ratios for matched and unmatched data: an update. Stata J. 2011;11:290–8.
Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:2968–77.
Chang DC, Zhang Y, Mukherjee D, et al. Variations in referral patterns to high-volume centers for pancreatic cancer. J Am Coll Surg. 2009;209:720–6.
Riall TS, Lillemoe KD. Underutilization of surgical resection in patients with localized pancreatic cancer. Ann Surg. 2007;246:181–2.
Shavers VL, Harlan LC, Jackson M, et al. Racial/ethnic patterns of care for pancreatic cancer. J Palliat Med. 2009;12:623–30.
Arnold LD, Patel AV, Yan Y, et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev. 2009;18:2397–405.
Morris AM, Rhoads KF, Stain SC, et al. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg. 2010;211:105–13.
Freeman HP, and Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005;14:655–69.
Landrum MB, Keating NL, Lamont EB, et al. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer. 2011. doi:10.1002/cncr.26628.
Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black–white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97:1211–20.
Dimou A, Syrigos KN, Saif MW. Disparities in colorectal cancer in African-Americans vs whites: before and after diagnosis. World J Gastroenterol. 2009;15:3734–43.
Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23:6639–46.
Morris AM, Billingsley KG, Hayanga AJ, et al. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008;100:738–44.
Sail K, Franzini L, Lairson D, et al. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethn Health. 2011. doi:10.1080/13557858.2011.628011.
Alexander DD, Waterbor J, Hughes T, et al. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark. 2007;3:301–13.
American College of Surgeons. CoC quality of cancer measures. Rev. March 2, 2011. http://www.facs.org/cancer/qualitymeasures.html.
Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93.
Yu JB, Gross CP, Wilson LD, et al. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009;23:288–95.
Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138:715–22.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wray, C.J., Castro-Echeverry, E., Silberfein, E.J. et al. A Multi-institutional Study of Pancreatic Cancer in Harris County, Texas: Race Predicts Treatment and Survival. Ann Surg Oncol 19, 2776–2781 (2012). https://doi.org/10.1245/s10434-012-2361-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-012-2361-z